Matthews, D. R. Et Al. 2019. Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes. DIABETIC MEDICINE , vol.36, no.4 , 505-513.

Matthews, D. R., Paldanius, P. M., Proot, P., Foley, J. E., Stumvoll, M., & Del Prato, S., (2019). Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes. DIABETIC MEDICINE , vol.36, no.4, 505-513.

Matthews, Hasan Et Al. "Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes," DIABETIC MEDICINE , vol.36, no.4, 505-513, 2019

Matthews, Hasan Et Al. "Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes." DIABETIC MEDICINE , vol.36, no.4, pp.505-513, 2019

Matthews, D. R. Et Al. (2019) . "Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes." DIABETIC MEDICINE , vol.36, no.4, pp.505-513.

@article{article, author={Hasan KUDAT Et Al. }, title={Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes}, journal={DIABETIC MEDICINE}, year=2019, pages={505-513} }